TY - JOUR
T1 - Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin
AU - Hussain, Abid
AU - Kairamkonda, Venkatesh
AU - Jenkins, David Richard
PY - 2011/3
Y1 - 2011/3
N2 - Daptomycin is licensed for the management of Staphylococcus aureus infections in adults, including those caused by meticillin-resistant S. aureus (MRSA). Few data exist on paediatric use or dose guidance in neonates. We report the case of a neonate with MRSA bacteraemia successfully managed with daptomycin. Dose requirements were substantially higher than those recommended for adults.
AB - Daptomycin is licensed for the management of Staphylococcus aureus infections in adults, including those caused by meticillin-resistant S. aureus (MRSA). Few data exist on paediatric use or dose guidance in neonates. We report the case of a neonate with MRSA bacteraemia successfully managed with daptomycin. Dose requirements were substantially higher than those recommended for adults.
UR - http://www.scopus.com/inward/record.url?scp=79951932614&partnerID=8YFLogxK
U2 - 10.1099/jmm.0.027235-0
DO - 10.1099/jmm.0.027235-0
M3 - Article
C2 - 21127158
AN - SCOPUS:79951932614
SN - 0022-2615
VL - 60
SP - 381
EP - 383
JO - Journal of Medical Microbiology
JF - Journal of Medical Microbiology
IS - 3
ER -